Kevin Connelly

Title: Innovations by Kevin Connelly in Extracellular Matrix Proteins

Introduction

Kevin Connelly is an accomplished inventor based in Los Angeles, CA. He holds three patents that focus on methods for producing extracellular matrix proteins. His work has significant implications in the fields of biotechnology and medicine.

Latest Patents

Connelly's latest patents include innovative methods for incorporating certain amino acid analogs into polypeptides produced by cells. This process is achieved by subjecting the cells to growth media containing these amino acid analogs. The degree of incorporation can be regulated by adjusting the concentration of amino acid analogs in the media and/or by modifying the osmolality of the media. Such incorporation allows for the alteration and study of the chemical and physical characteristics of polypeptides. Additionally, his patents provide nucleic acids and corresponding proteins that include domains from physiologically active peptides and extracellular matrix proteins capable of self-aggregation. Notably, human extracellular matrix proteins that can provide self-aggregate collagen are produced by prokaryotic cells, utilizing preferred codon usage for optimal production.

Career Highlights

Throughout his career, Kevin Connelly has worked with notable companies, including United States Surgical Corporation and its division, Tyco Healthcare Group. His contributions to these organizations have helped advance the field of surgical and medical technologies.

Collaborations

Connelly has collaborated with esteemed colleagues such as Elliott A. Gruskin and